-
Mashup Score: 7Top Studies From the 2023 International Stroke Conference - 1 year(s) ago
Studies on stroke thrombectomy, statins, and imaging are among Dr Hans-Christoph Diener’s top picks from the 2023 International Stroke Conference.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Tirofiban Superior to Aspirin in Stroke Without Large Occlusion - 1 year(s) ago
Among patients with disabling strokes without medium or large occlusions, more of those taking tirofiban had good function at 90 days than those on aspirin, results of the RESCUE BT2 trial show.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
New research suggests some patients do better with tirofiban than with low-dose aspirin following disabling #stroke without a visible large or medium intracranial vessel occlusion. #ISC23 https://t.co/5DtjrQdsdJ
-
-
Mashup Score: 0Genes, neighborhoods and a surprising finding on stroke risk - 1 year(s) ago
A genetic score may be able to identify higher stroke risk – but only for people living in the most privileged neighborhoods, preliminary research has found.
Source: www.heart.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Researchers wanted to know whether living in a privileged versus deprived neighborhood affected someone’s genetic risk for stroke. It did, but not in the way they expected. #ISC23 https://t.co/YnmWTd9LzS
-
-
Mashup Score: 0Thrombectomy Benefits Stroke With Large Core Volumes: SELECT2 - 1 year(s) ago
A new international trial has shown large benefits of thrombectomy in patients with ischemic strokes with a large core volume, which should lead to a change in clinical practice.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
A 🆕 international trial has shown large benefits of thrombectomy in patients with ischemic strokes with a large core volume, which should lead to a change in clinical practice. https://t.co/M4eHAObrJn #ISC23
-
-
Mashup Score: 4Stroke OnDemand - 1 year(s) ago
Stroke OnDemand is a digital collection of some of the best programming from the International Stroke Conference. Earn CE and increase your brain health knowledge.
Source: professional.heart.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ICYMI: Here are all late-breaking science summary results from #ISC23. For more data, check out ISC OnDemand: https://t.co/MuANrSDb4f https://t.co/IHvffy8mG3
-
-
Mashup Score: 0Novel Celery Seed–Derived Drug May Improve Stroke Outcomes - 1 year(s) ago
The drug, butylphthalide, was associated with better outcomes after ischemic stroke after thrombolysis or endovascular therapy.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#ISC23 Butylphthalide may improve outcomes after an acute ischemic stroke when given in addition to thrombolysis or endovascular treatment, a new report suggests. https://t.co/7cmHC4wJH5
-
-
Mashup Score: 2Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Latest Headlines, NeurologyTweet-
Did you miss #ISC23? Catch up on the latest research #AtTheMeetings: https://t.co/h07L6yv5WR #neurotwitter #stroke #NeurologyToday @AANMember https://t.co/YRR2XBybNl
-
-
Mashup Score: 0Blood Pressure–Lowering After Thrombectomy May Be Harmful - 1 year(s) ago
Preliminary results of a new study showed that using an antihypertensive drug to target systolic blood pressure to below 160 mm Hg or 140 mm Hg in these patients may not be beneficial, and may even be harmful.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Artificially lowering BP in stroke patients following endovascular therapy is not necessarily a good strategy, new research suggests. #ISC23 https://t.co/MsB1UODc5H
-
-
Mashup Score: 5Thrombolysis Not Necessary in Mild Nondisabling Stroke: ARAMIS - 1 year(s) ago
Dual antiplatelet treatment was noninferior to thrombolysis with regard to functional outcome at 90 days for Chinese patients with minor nondisabling stroke.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
Dual antiplatelet treatment was noninferior to thrombolysis with regard to functional outcome at 90 days for Chinese patients with minor nondisabling stroke. #ISC23 https://t.co/Juabw5QVOJ https://t.co/Sw9cGRLyM6
-
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Latest Headlines, NeurologyTweet-
Via #ISC23: Two generic drugs long used to treat cardiac and circulatory problems appear to reduce adverse outcomes, including cognitive decline, when given to patients following a lacunar #stroke: https://t.co/WXWjyh3yQ3 https://t.co/LWnGAnEh44
-
Post-stroke statins: New data #ISC23 https://t.co/5THFRz3I2Z https://t.co/pCsGbEXhDr